These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2340080)

  • 21. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
    Grzonka Z; Lammek B; Kasprzykowski F; Gazis D; Schwartz IL
    J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
    Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
    J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular-dichroic spectra of vasopressin analogues and their cyclic fragments.
    Fric I; Kodícek M; Flegel M; Zaoral M
    Eur J Biochem; 1975 Aug; 56(2):493-502. PubMed ID: 240713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural requirements of the oxytocin receptor in rat uterus. Free-Wilson analysis in a series of competitive oxytocin inhibitors.
    Pliska V; Heiniger J
    Int J Pept Protein Res; 1988 Jun; 31(6):520-36. PubMed ID: 2842268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some pharmacologic studies on 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin: two potent oxytocin inhibitors.
    Chan WY; Fear R; Du Vigneaud V
    Endocrinology; 1967 Dec; 81(6):1267-77. PubMed ID: 6064990
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity studies of a novel bicyclic oxytocin antagonist.
    Smith DD; Slaninova J; Hruby VJ
    J Med Chem; 1992 May; 35(9):1558-63. PubMed ID: 1578481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activities of oxytocin and lysine vasopressin analogs containing glutamic acid gamma-hydrazide in position 4.
    Gazis D; Glass J; Schwartz IL; Stavropoulos G; Theodoropoulos D
    Int J Pept Protein Res; 1989 Nov; 34(5):353-7. PubMed ID: 2613436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution conformation of a retro-D analogue of tocinamide.
    Kopple KD; Dickinson HR; Nakagawa SH; Flouret G
    Biochemistry; 1976 Jul; 15(14):2945-52. PubMed ID: 952844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological activity of a new analogue of oxytocin in which the tyrosyl group is replaced by phenylalanyl.
    KONZETT H; BERDE B
    Br J Pharmacol Chemother; 1959 Mar; 14(1):133-6. PubMed ID: 13651590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular dichroism studies of some arginine-vasopressin analogues.
    Grzonka Z; Gwizdała E; Kasprzykowski F; Lankiewicz L
    Biophys Chem; 1988 Aug; 31(1-2):87-100. PubMed ID: 3233295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.